Capricor provides top-line update from HOPE-2 open label extension trial

CAPRICOR THERAPEUTICS, INC.

Capricor reported top-line results from HOPE-2 OLE (1-year data) via slide presentation on June 27, 2022.
The slide presentation was made available on the company's website; specific data not detailed in the filing.
No numerical results or endpoint data are included in the filed exhibit; only a title slide is reproduced.
The update was disclosed under Regulation FD; a conference call was held the same day.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.